Modrák, 213 patient HCQ late treatment study: 59% lower mortality [p=0.04] https://c19p.org/modrak
copied to clipboard
Detailed disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic: An exploratory analysis
et al., medRxiv, doi:10.1101/2020.12.03.20239863 (Preprint)
Retrospective 213 hospitalized patients in Czech Republic showing lower mortality with HCQ. Subject to confounding by indication.
|
risk of death, 59.0% lower, RR 0.41, p = 0.04, treatment 108, control 105, Cox (single).
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Modrák et al., 12/4/2020, retrospective, Czech Republic, Europe, preprint, 26 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.